HOME >> MEDICINE >> NEWS
Control of TB epidemic requires more effective drugs, better tests, and focus on latent infection

ATLANTA--With approximately 9 million individuals expected to develop tuberculosis (TB) this year and more than 2 million expected to die from the disease, according to the World Health Organization, tuberculosis has become a global public health epidemic. In the U.S., although TB cases have declined since 1992, it remains a serious health problem in urban areas and among certain populations including some U.S.-born persons. The global TB epidemic increasingly impacts the U.S., where the majority of TB cases now occurring are among people born outside the country.

In an article in the Journal of the American Medical Association published on-line on Tuesday, June 7, clinician/researchers describe the most current effective treatments for both active TB and latent TB infection and the efforts underway to develop new drugs and more effective diagnostic tools. A stepped-up effort targeting programs to detect and treat the large number of people with latent TB infection who are at increased risk for progression to active TB is a strategy for enhancing TB control efforts in the U.S., the authors say.

Effective treatment of active TB requires a minimum of six to nine months of multi-drug therapy. To ensure successful completion of the therapy, these drugs should be administered by using "directly observed therapy," which requires that a health care worker give a patient the drugs then watch the patient swallow them. Directly observed therapy has been demonstrated to enhance completion and cure rates and reduce the risk of emergence of drug-resistant TB.

"Enhancing control of TB in the U.S. requires close collaboration between public health programs and private clinicians," says Henry Blumberg, MD, professor of medicine (infectious diseases) at Emory University School of Medicine, director of infection control at Atlanta's Grady Memorial Hospital and lead author of the JAMA paper. "Our goals with treatment are to cure patients, minimize the
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
7-Jun-2005


Page: 1 2 3

Related medicine news :

1. Controlling prescription drug expenditures: a case report of success
2. SAGE to publish British Journal of Infection Control
3. Controlling antibiotics and antibiotic resistance in hospitals
4. Controlling behavior of children with tourette and tic disorders
5. $900,000 for first Canadian Chair in Hypertension Prevention and Control
6. IAMP expresses support for Disease Control Priorities Project
7. Controlling blood sugar in hospitalized patients saves lives
8. Controlling your (nerve) impulses
9. Controlling neglected tropical diseases will boost fight against HIV, TB, and malaria
10. Controlling neglected tropical diseases could help make poverty history
11. Cigarette use may explain asthma epidemic in children, says Mailman School of Public Health study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... 19, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... statutory advisor to the U.S. Department of Health and Human Services (HHS), today issued ... was issued following the release last week at the HIMSS Global Conference and Exhibition ...
(Date:2/19/2019)... ... 2019 , ... In one of the first research studies ... team led by a Worcester Polytechnic Institute professor found that women who experience ... weight gain during pregnancy, and weight retention after their baby is born. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Alejandro ... patients with or without a referral who are interested in full arch permanent ... Kovacs routinely places All-on-4® dental implants in Texarkana, TX, for those ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... opioid epidemic with town halls across the country , A partnership between Liberty ... nationwide opioid crisis, continues with its next town hall event on Tuesday, February ...
(Date:2/19/2019)... ... February 19, 2019 , ... Catalent ... solutions for drugs, biologics and consumer health products, today announced that Michael ... Bioassay Conference of the BioPharmaceutical Emerging Best Practices Association (BEBPA), taking place ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... , ... February 19, 2019 , ... ... cure for Job Syndrome by providing the scientific community with additional opportunities to ... Alain Fischer as Chief Scientific Officer of the Foundation’s Scientific Advisory Board and ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... RCH ... firms of all sizes, announces the hiring of Frank Iafrato as Director of Sales ... to deepen the firm’s sales coverage throughout the Northeast region, building upon the momentum ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... for gum disease that utilizes modern dental lasers. The Laser Assisted New Attachment ... bacteria and diseased tissue, the leading cause of gum disease. Dr. Farahmand is ...
Breaking Medicine Technology:
Cached News: